Cataract surgery remains one of the most commonly performed procedures in the world. In the past few years, there have been many advancements in the field of ocular and refractive surgery. Pharmaceutical companies and manufacturers are constantly thinking about ways to make cataract surgery more effective and efficient. Though multifocal IOLs have been the shining stars of innovation in the past years, the light-adjustable is arguably the most talked-about newcomer.
The light-adjustable IOL was created to address variable post-surgical outcomes, a very common problem following traditional cataract surgery. Since this variation differs from patient to patient, there has never been one solid way to approach the problem of not reaching the perfect target prescription following surgery.